Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cross talk between redox signalling and metabolic activity of osteoblasts and fibroblasts in the presence of hydroxyapatite-based biomaterials influences bone regeneration

Ewa Ambrożewicz, Grażyna Tokajuk, Marta Muszyńska, Ilona Zaręba, Elżbieta Skrzydlewska

. 2019 ; 17 (2) : 125-135.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc19032534

Regeneration of bone tissue defects that result from metabolic disorders, including periodontal diseases, can be supported by biomaterials based on hydroxyapatite. Despite of good biocompatibility of biomaterials they can cause oxidative stress and inflammatory processes as a result of mechanical interaction with surrounding tissues. Because osteoblasts are responsible for bone regeneration process in which gingival fibroblasts may also participate, the aim of the work was to investigate the influence of hydroxyapatite-based biomaterials (allogeneic and xenogeneic) and biomaterials combined with enamel matrix derivative (Emdogain) on osteoblast and fibroblast redox balance in the context of osteoblast proliferation and differentiation. The results showed that examined substitutes were not cytotoxic in vitro, but affected redox balance of osteoblasts and fibroblasts (ROS level increase and GSH level decrease) which led to oxidative stress (MDA and protein carbonyl groups level increase) resulting in an increase of the Nrf2 and NFκB expression. The consequence of these changes was partial inhibition of proliferation and osteoblast differentiation. Emdogain alone and combined with biomaterials decreased ROS generation and increased GSH level in both osteoblasts and fibroblasts leading to reduction of transcription factors expression especially proinflammatory NFκB, which promoted osteoblast differentiation and mineralization process.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc19032534
003      
CZ-PrNML
005      
20200420115107.0
007      
ta
008      
190923s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.32725/jab.2019.004 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Ambrożewicz, Ewa $u Medical University of Bialystok, Faculty of Pharmacy, Department of Analytical Chemistry, Bialystok, Poland
245    10
$a Cross talk between redox signalling and metabolic activity of osteoblasts and fibroblasts in the presence of hydroxyapatite-based biomaterials influences bone regeneration / $c Ewa Ambrożewicz, Grażyna Tokajuk, Marta Muszyńska, Ilona Zaręba, Elżbieta Skrzydlewska
504    __
$a Literatura
520    9_
$a Regeneration of bone tissue defects that result from metabolic disorders, including periodontal diseases, can be supported by biomaterials based on hydroxyapatite. Despite of good biocompatibility of biomaterials they can cause oxidative stress and inflammatory processes as a result of mechanical interaction with surrounding tissues. Because osteoblasts are responsible for bone regeneration process in which gingival fibroblasts may also participate, the aim of the work was to investigate the influence of hydroxyapatite-based biomaterials (allogeneic and xenogeneic) and biomaterials combined with enamel matrix derivative (Emdogain) on osteoblast and fibroblast redox balance in the context of osteoblast proliferation and differentiation. The results showed that examined substitutes were not cytotoxic in vitro, but affected redox balance of osteoblasts and fibroblasts (ROS level increase and GSH level decrease) which led to oxidative stress (MDA and protein carbonyl groups level increase) resulting in an increase of the Nrf2 and NFκB expression. The consequence of these changes was partial inhibition of proliferation and osteoblast differentiation. Emdogain alone and combined with biomaterials decreased ROS generation and increased GSH level in both osteoblasts and fibroblasts leading to reduction of transcription factors expression especially proinflammatory NFκB, which promoted osteoblast differentiation and mineralization process.
650    12
$a řízená tkáňová regenerace $x metody $7 D048091
650    _2
$a biokompatibilní materiály $7 D001672
650    _2
$a kostní náhrady $x farmakologie $x metabolismus $7 D018786
650    _2
$a techniky in vitro $7 D066298
650    _2
$a osteoblasty $x metabolismus $x účinky léků $7 D010006
650    _2
$a hydroxyapatity $x farmakologie $x metabolismus $x škodlivé účinky $7 D006882
650    _2
$a fibroblasty $x metabolismus $x účinky léků $7 D005347
650    _2
$a oxidace-redukce $x účinky léků $7 D010084
650    _2
$a proteiny zubní skloviny $x farmakologie $x metabolismus $7 D003746
700    1_
$a Tokajuk, Grażyna $u Medical University of Bialystok, Faculty of Medicine, Department of Integratet Dentistry, Bialystok, Poland
700    1_
$a Muszyńska, Marta $u Medical University of Bialystok, Faculty of Pharmacy, Department of Analytical Chemistry, Bialystok, Poland
700    1_
$a Zaręba, Ilona $u Medical University of Bialystok, Faculty of Pharmacy, Department of Medicinal Chemistry, Bialystok, Poland
700    1_
$a Skrzydlewska, Elżbieta $u Medical University of Bialystok, Faculty of Pharmacy, Department of Analytical Chemistry, Bialystok, Poland
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 17, č. 2 (2019), s. 125-135 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/pdfs/jab/2019/02/05.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2301 $c 1249 $y p $z 0
990    __
$a 20190923112237 $b ABA008
991    __
$a 20200420115103 $b ABA008
999    __
$a ok $b bmc $g 1446015 $s 1071039
BAS    __
$a 3
BMC    __
$a 2019 $b 17 $c 2 $d 125-135 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK125 $d 20200420 $a NLK 2019-36/dk

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...